TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

OCUVEX THERAP

CardiovascularOphthalmology
Pharma

OCUVEX THERAP is a pharmaceutical company focused on Cardiovascular, Ophthalmology. Key products include OMLONTI.

2022
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

OMLONTI
omidenepag isopropyl
EP2 receptor 2 indications · 2022

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 50%
1 drugs
Ophthalmology 50%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Novartis big-pharma
Cardiovascular, Ophthalmology
Baxter specialty
Cardiovascular, Ophthalmology
Bayer big-pharma
Cardiovascular, Ophthalmology
B BRAUN specialty
Ophthalmology, Cardiovascular
BAUSCH specialty
Ophthalmology, Cardiovascular